Submit an abstract for the Spotlight on Immuno-Oncology conference by June 2, 11:59 p.m. PT
This award, supported by Phil and Nancy Reilly, highlights the contributions of leading early-career authors to the Molecular Therapy family of journals.
The award recipient will be:
An ASGCT member in good standing
The first author on an original research article published in the Molecular Therapy family of journals in the previous calendar year
All lead authors meeting these criteria are eligible. The best article published in each journal will be determined by the editor-in-chief and associate editors. The editors will consider factors such as novelty, innovation, and significance when evaluating articles.
The recipients of the award will be announced in advance of the 2023 Annual Meeting and will receive a cash award of $2,500 and a plaque. Nominations open through February 28, 2023.
To nominate yourself or a colleague(s), please submit the nominee's name and the journal article to awards@asgct.org.
Sept. 18-19 | Washington, DC
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico